Clinical metagenomics—challenges and future prospects
Frontiers in Microbiology · 28.06.2023 · 14
DOI: 10.3389/fmicb.2023.1186424 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 28.06.2023. Verfasst von Maliha Batool und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, United Stat…. Die Arbeit wurde bisher 95-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Infections lacking precise diagnosis are often caused by a rare or uncharacterized pathogen, a combination of pathogens, or a known pathogen carrying undocumented or newly acquired genes. Despite medical advances in infectious disease diagnostics, many patients still experience mortality or long-term consequences due to undiagnosed or misdiagnosed infections. Thus, there is a need for an exhaustive and universal diagnostic strategy to reduce the fraction of undocumented infections. Compared to conventional diagnostics, metagenomic next-generation sequencing (mNGS) is a promising, culture-independent sequencing technology that is sensitive to detecting rare, novel, and unexpected pathogens with no preconception. Despite the fact that several studies and case reports have identified the effectiveness of mNGS in improving clinical diagnosis, there are obvious shortcomings in terms of sensitivity, specificity, costs, standardization of bioinformatic pipelines, and interpretation of findings that limit the integration of mNGS into clinical practice. Therefore, physicians must understand the potential benefits and drawbacks of mNGS when applying it to clinical practice. In this review, we will examine the current accomplishments, efficacy, and restrictions of mNGS in relation to conventional diagnostic methods. Furthermore, we will suggest potential approaches to enhance mNGS to its maximum capacity as a clinical diagnostic tool for identifying severe infections.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, United States.
Förderung
- NIAID NIH HHS
Zitieren
APA
Batool, M., & Galloway-Peña, J. (2023). Clinical metagenomics—challenges and future prospects. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1186424
Vancouver
Batool M, Galloway-Peña J. Clinical metagenomics—challenges and future prospects. Frontiers in Microbiology. 2023;14. doi:10.3389/fmicb.2023.1186424
BibTeX
@article{Batool2023,
author = {Batool, Maliha and Galloway-Peña, Jessica},
title = {Clinical metagenomics—challenges and future prospects},
journal = {Frontiers in Microbiology},
year = {2023},
volume = {14},
doi = {10.3389/fmicb.2023.1186424}
}
EUVIMED